We were approved for clinical trials of ambrisentan tablets.
The "R&D and Industrialization Project of Refined Crystallization Technology of High-end Pharmaceutical Products" won the Second Prize of National Science and Technology Progress Award
The "Anti-hypertensive Drugs, Losartan Related Green Key Technology Development and Industrialization Project" won the second prize of National Science and Technology Progress Award (2014)
In January 2009, the ACEIs (angiotensin converting enzyme inhibitors) related key technology development and industrialization project of the Company won the "Second Prize of National Science and Technology Progress Award"